LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Net margin 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) net profit margin by fiscal year — reported net income divided by reported revenue.
-30.0%FY2025 · since FY2016: -2.4% → -30.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -30.0% | -39.4 pp |
| FY2024 | 9.4% | +105.8 pp |
| FY2023 | -96.4% | +8.5 pp |
| FY2022 | -104.9% | -72.9 pp |
| FY2021 | -32.0% | -8.2 pp |
| FY2020 | -23.9% | -23.9 pp |
| FY2019 | 0.1% | -4.7 pp |
| FY2018 | 4.7% | +2.5 pp |
| FY2017 | 2.3% | +4.7 pp |
| FY2016 | -2.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net incomeLFCR Gross profitLFCR Gross marginLFCR Operating incomeLFCR Operating marginLFCR Operating cash flowLFCR Free cash flowLFCR Capital expendituresLFCR Return on equityLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Total liabilitiesLFCR Shareholders’ equityLFCR overview →